Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-500-6530
Dr. Gay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Medical Oncology, 2015 - 2019- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2013 - 2016
New York University School of MedicineClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2017 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
AZ State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas Start of enrollment: 2021 Feb 01
Publications & Presentations
PubMed
- Timing of local consolidative pulmonary resection for oncogene-driven stage IV lung cancer.Mara B Antonoff, Carl M Gay
The Journal of Thoracic and Cardiovascular Surgery. 2025-04-03 - Receptor Tyrosine Kinase Fusion-Mediated Resistance to EGFR TKI in EGFR-Mutant NSCLC: A Multi-Center Analysis and Literature Review.Yang Xia, Kaiwen Wang, Jing Zhao, Zhaohui Arter, Yongchang Zhang
Journal of Thoracic Oncology. 2025-04-01 - Longitudinal Tracking of-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA.Simon Heeke, Saumil Gandhi, Hai T Tran, Vincent K Lam, Lauren A Byers
JTO Clinical and Research Reports. 2025-04-01
Press Mentions
Advances in Small Cell Lung Cancer ClassificationNovember 25th, 2024- MD Anderson Research Highlights for September 19, 2024September 19th, 2024
- MD Anderson Research Highlights for August 21, 2024August 21st, 2024
- Join now to see all
Grant Support
- Detection and elimination of drug tolerant persister cells in small cell lung cancerUNIVERSITY OF TX MD ANDERSON CAN CTR2025–2030
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
